ips 339 has been researched along with sotalol in 1 studies
Studies (ips 339) | Trials (ips 339) | Recent Studies (post-2010) (ips 339) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
---|---|---|---|---|---|
26 | 0 | 0 | 2,196 | 346 | 291 |
Protein | Taxonomy | ips 339 (IC50) | sotalol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerber, JG; Nies, AS; Olson, RD | 1 |
1 other study(ies) available for ips 339 and sotalol
Article | Year |
---|---|
Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Dogs; Female; Indomethacin; Isoproterenol; Kidney; Male; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin; Sotalol; Stimulation, Chemical | 1982 |